New insights into naevoid melanomas: a clinicopathological reassessment
Aims: Because the term 'naevoid melanoma' has variable clinical and pathological interpretations, we aimed to clarify the features of melanomas referred to as naevoid. Methods and results: A review was undertaken of 102 melanomas diagnosed histopathologically as naevoid melanomas and ascertained by European Organization for Research and Treatment of Cancer Melanoma Group Subcommittee pathologists from their records. We found these could be classified morphologically into three groups. Thirteen melanomas were overlying genuine naevi and were therefore excluded. Of the 89 melanomas considered to be naevoid, 11 presented clinically as exophytic papillomatous nodules with little junctional component and composed of small atypical cells showing numerous mitoses and no change with depth; we termed these 'papillomatous naevoid' melanomas. The other 78 were flat or only slightly raised, and had a superficial spreading melanoma-like component with maturation to a small cell, but still an atypical, dermal component; we termed these 'maturing naevoid' melanomas. We showed that papillomatous and maturing naevoid melanomas also have differing immunochemical profiles. Preliminary clinical follow-up suggested different outcomes for these two naevoid melanoma types. Conclusions: Melanomas that have been classified as naevoid melanomas comprise two types with distinct clinical, histopathological and immunohistochemical features that may also be prognostically significant.
Introduction
Although the term 'naevoid melanoma' could potentially describe a melanoma that resembles any variant of melanocytic naevus, the term is usually restricted to relatively uncommon melanomas resembling common intradermal or compound naevi in which the dermal component predominantly comprises small naevoid cells. Some of these lesions can be easily mistaken for benign naevi and may only be recognised when a recurrence occurs.
1,2 The existence of such melanomas was noted originally by Levene, 3 and by others subsequently. 4, 5 The previous term 'minimal deviation melanoma' 6 possibly included naevoid melanomas, and they have also been referred to as small-cell melanoma. 7, 8 Ruhoy et al., 9 in describing a melanoma with paradoxical maturation, appeared to be referring to the same lesion that Blessing et al. 8 termed 'small-cell naevoid melanoma'. Such practices have resulted in confusion among pathologists and clinicians treating patients with potentially different lesions but with the same diagnostic label. The aim of this study was to re-evaluate the histological and clinical features of naevoid melanomas in order to clarify whether lesions so classified include one or more types of melanoma.
Materials and methods
The study was approved by the Royal Surrey County Hospital Ethics Committee (07/Q190913). All cases diagnosed as naevoid melanoma in the period 2004-2016 were retrieved from the files of members of the Pathology Subcommittee of the European Organization for Research and Treatment of Cancer Melanoma Group (EORTC MG) and the consultation files of one of us (M.G.C.). Cases were included if histological sections were available and the patient's age, sex and anatomical site of lesion were known. Naevoid lesions resembling Spitz naevi, and other lesions such as deep penetrating naevi and blue naevi, were regarded as separate entities and were specifically excluded.
All eligible cases underwent histological review of the features in the Royal College of Pathologists Data Set 10 for melanomas on original haematoxylin and eosin-stained sections. Immunohistochemical staining of further sections of all cases of both subtypes was carried out to descriptively characterise the tumours.
The 64 maturing naevoid melanomas for which blocks were available were further stained with CD44 and markers that might help to explain the phenomenon of maturation. For example, reticulin staining was carried out as a measure of stroma around naevus or melanoma cells, and p16 and RRM2 stains were chosen to reflect senescence. Other markers employed on 24 of the 64 maturing naevoid melanomas were p21, E-cadherin, N-cadherin, WHSC1/ NSD2 and 5-hydroxymethylcytosine (5-hmC). Negative controls with normal serum replacing primary antibodies were employed throughout. The antibodies HMB-45, MIB-1, anti-p16, anti-E-cadherin and CD44 were obtained from Dako, (Ely, UK) anti-N-cadherin was obtained from Leica Biosystems, (Milton Keynes, UK) and anti-RRM2 was obtained from Abcam (Cambridge, UK). Staining for p21 was performed in Rotterdam (by S.K.), that for WHSC1/NSD2 was performed in Leuven (J.v.d.O.), and that for 5-hmC was performed in Boston by courtesy of C. Lian. 11 All cases were assessed systematically by a single pathologist (M.G.C.), and independently reviewed by other members of the EORTC MG Pathology Group with a multihead microscope. Any disagreement was resolved in discussion.
Molecular analysis was performed on 11 cases for which paraffin tissue was available. DNA from microdissected formalin-fixed paraffin-embedded material was isolated with GeneRead DNA FFPE kits (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Polymerase chain reaction-based target enrichment and next-generation sequencing were performed as previously described. 12 
Results
Between 2004 and 2016, 102 cases were retrieved from the participating pathologists' files. On initial review, 13 melanomas associated with a benign preexisting naevus were excluded, leaving 89 naevoid melanoma cases for study.
P A T I E N T F E A T U R E S
The average age of patients with papillomatous naevoid melanoma was 40 years (range 12-89 years), the average age of patients with maturing naevoid melanoma was 56 years (range 16-89 years) (P = 0.001), and males comprised 40% and 56%, respectively. Of the papillomatous subtype, 40% were on the head and 60% on the trunk, whereas of the maturing subtype, 8% were on the head, 44% were on the trunk, and 48% were on the limbs.
H I S T O L O G Y
Detailed histology showed that the 89 cases separated into two groups with distinctly different patterns of growth (Table 1 ). One group of 11 cases showed an exophytic papillomatous configuration ( Figures 1-4) , herein termed 'papillomatous naevoid' melanoma. This group, resembling predominantly intradermal naevi, had a mean thickness of 2.0 mm (range 1.3-3.7 mm). The epidermis showed prolongations into the underlying lesion with only scanty or focal junctional proliferation of melanocytes (Figure 1 ), and occasionally a complete absence of junctional melanocytes. The epidermal prolongations appeared to divide the underlying melanocytes into lobules. The constituent melanocytes appeared small, mainly owing to a lack of cytoplasm, but the nuclei were larger than those of a dermal naevus, and appeared hyperchromatic and often angulated and faceted against each other (Figure 2 ). Mitoses were always present (mean count of 5.9 per mm 2 ; range 4-7), and the proliferation marker MIB-1 showed a band of cells with a high proportion of positivity adjacent to the epidermal prolongations ( Figure 3) . The melanocytes did not show maturation but, in two cases, the underlying dermis included benign naevus cells (Figure 4) , allowing a direct comparison with the naevoid melanoma cells. Apart from differences in size, shape, and chromicity, the tumour cells were surrounded by a less conspicuous collagenous stroma and reticulin framework in groups of three to five cells, whereas the collagen in pre-existing naevi was more prominent, and reticulin surrounded smaller groups of cells.
The second larger group comprised 78 cases of largely flat or shallow dome-shaped lesions distinguished by their histology as superficially invasive melanoma predominantly of the superficial spreading melanoma type but showing a change in cell type in the superficial dermis (Table 1) . We termed these 'maturing naevoid' melanomas. The mean thickness was 0.9 mm (range 0.4-3.0 mm), and there were few mitoses (mean mitotic rate of 0.7 per mm 2 ; range 0-1). The evidence of malignancy in this group comprised the histological features of atypia and tumour architecture that indicated infiltration of the dermis. Specifically, the maturing variants had a disorderly junctional proliferation of severely atypical melanocytes ( Figure 5) , with similar cells extending into the superficial dermis but to a variable depth before showing a change in cell type and arrangement (Figure 6 ). With depth, the cells became smaller, with less cytoplasm and round hyperchromatic nuclei, and showed an irregular nested pattern. Light melanin pigmentation was usually evident in the cytoplasm ( Table 1 ).
The essential feature of this maturing naevoid group was the change in cell type at varying levels in the papillary dermis or superficial reticular dermis. The small naevoid cells either showed a sheet-like arrangement ( Figure 6 ) with nesting more deeply or an immediate nesting pattern surrounded by dense collagen (Figure 7) . The nests tended to be larger in the deeper part of the lesion, in the same pattern described by others. 7 Although the deeper cells could be said to be naevoid, in the 13 cases in which a true pre-existing naevus was present the distinction was clear (Figure 8) . This was attributable to the larger hyperchromatic nuclei and their grouping together with reticulin surrounding irregular groups within the larger aggregates, in contrast to the smaller naevus cells with reticulin around smaller groups of cells. Of the 78 cases of maturing naevoid melanoma, there were 19 in which this process did not affect the full width of the lesion. The maturation ranged from focal, affecting 10-20% of the lesion (five cases), to nearly complete, affecting 80-90% of the lesion (one case).
I M M U N O H I S T O C H E M I S T R Y
Immunohistochemical staining in the papillomatous naevoid melanomas (Table 2 ) indicated active proliferation, and showed characteristics associated with malignancy. In addition, CD44 showed uniform strong membranous staining. RRM2 staining was strong throughout.
In contrast, immunohistochemistry of all 78 maturing naevoid melanomas showed a diminution in proliferative activity in the deeper component, and other markers also showed features tending towards senescence (Figure 9 ). In cases showing lack of uniformity, such immunochemical findings applied only to the part with features suggesting maturation. In the maturing naevoid melanomas stained with RRM2, the maturing part of the tumour was no longer represented in seven cases, but the superficial invasive component was positive in all. In the 13 cases in which both superficial and maturing components remained available for assessment, three showed weak or negative staining in the deep maturing components, but the rest remained positive.
M O L E C U L A R A N A L Y S I S
We analysed one to three microdissected areas of 11 available cases: three papillomatous and eight maturing naevoid melanomas. Specifically, we performed targeted sequencing of BRAF and NRAS by using next-generation sequencing technology. All three papillomatous naevoid cases carried a hotspot mutation in NRAS (seen consistently across one, two and three microdissected areas for each case, respectively), but were wild type for BRAF (Table 2) . Of the eight maturing naevoid melanomas, two carried a BRAF hotspot mutation (consistently observed across two and four microdissected areas, respectively), four carried an NRAS hotspot mutation (consistently observed across up to three microdissected areas), and two were wild type for both BRAF and NRAS (Table 2) .
Early follow-up data were available for 90% patients with the papillomatous type (average follow-up, 3.3 years) and 64% of those with the maturing type (average follow-up, 2 years). In-transit or lymph node metastases had occurred in 33% of patients with papillomatous naevoid melanomas (with measured thicknesses of <1.0, 2.1, and 3.7 mm, respectively), but no disease progression was seen in those with maturing naevoid melanomas (including two with measured thicknesses of 3.0 and 3.5 mm, respectively).
Discussion
In this study of atypical melanocytic tumours with features of benign melanocytic naevi and melanoma, we confirmed that most cases could be classified as 20 µm Figure 7 . A different maturing naevoid melanoma showing a change from epithelioid pleomorphic nested melanocytes in the superficial dermis to, in the deeper part, smaller but still atypical cells arranged in nests surrounded by dense collagen. Figure 8 . A maturing naevoid melanoma in which small atypical melanocytes in the superficial dermis are arranged in nests surrounded by dense collagen. A true benign naevus is present at the deep aspect of this melanoma. melanoma on the basis of atypia, a disorderly growth pattern, or mitoses. These could be separated into two groups: one resembling a raised predominantly intradermal naevus, which we termed 'papillomatous naevoid', and a second resembling a compound naevus with junctional dysplasia, which we termed 'maturing naevoid'. The less frequent papillomatous naevoid group has been previously described by Blessing et al. 8 as being similar to benign naevi but potentially aggressive, and by others, 3, 4, 13 who also noted a similar prognosis to that of other melanomas, with recurrence and a metastatic rate of 50% being reported 2 for papillomatous naevoid melanomas. 8 referred to them as small-cell variants of naevoid melanoma that may be less aggressive than other melanomas. Ruhoy et al. 9 described them as melanoma with paradoxical maturation without mention of differences in behaviour, whereas others 14 recognised papillomatous and non-papillomatous naevoid melanomas corresponding to our findings but, again, did not note any differences in behaviour between the two morphological types. Kossard and Wilkinson 7 described a small-cell naevoid melanoma with a lentiginous epidermal component and features that appear to be similar to those of some of our maturing naevoid melanomas. They noted a nested dermal component with fibrosis, and they suspected a less aggressive behaviour.
µm
On the other hand, Y elamos et al. 15 described naevoid melanoma as a heterogeneous group, those with high-grade atypia having a worse prognosis. Figure 9 . An example of immunohistochemical staining. p21 is seen to be positive in the junctional and superficial dermal component of another maturing naevoid melanoma, but is largely negative in the deeper small-cell component.
Our observations of two distinct types of naevoid melanoma were supported by immunochemical differences. All papillomatous variants showed raised Ki67/MIB-1 counts, consistent with their marked proliferative activity, whereas the maturing naevoid cells showed staining with p16 and 5-hmC, consistent with them being intermediate between melanoma and true naevus cells, 12 presumably suggesting progression towards senescence. Indeed, the immunohistochemical data raise the question of whether the maturing naevoid melanoma is appropriately classified. RRM2 was present in the superficial dermal part, supporting their classification as invasive melanomas, and senescence not being the sole basis of the observed changes. 16 At present, maturing naevoid lesions appear to be appropriately classified as melanomas, but the intralesional changes suggest acquisition of a less aggressive behaviour, and our preliminary follow-up data support this notion. Finally, the molecular findings that all three of the papillomatous naevoid cases carried a hotspot mutation in NRAS but were wild type for BRAF was a striking result even in so small a cohort, given that BRAF is the most commonly mutated melanoma driver gene. The observations for the eight maturing naevoid melanomas largely recapitulated previous findings that NRAS and BRAF hotspot mutations are generally mutually exclusive (in one case, a non-hotspot BRAF mutation was observed in two of the three microdissected areas of an NRAS-mutated maturing naevoid melanoma), although the more common occurrence of NRAS mutations than of BRAF mutations was notable. A larger cohort of cases would need to be analysed at the molecular level to assess whether these types of lesion are more commonly driven by RAS.
Although it is well known that many tumours, including melanoma, show heterogeneity, it is less accepted that tumours that have acquired properties of invasion and proliferation can reverse those properties. Whether the observations are correctly interpreted as maturation 9 and whether this is a response to cell signalling, suppressed mutations, or an effect produced by the microenvironment, are unknown, and we will seek to address these questions in further studies.
